Funding Programmes in Europe and the World: The Naked Reality
Many founders begin with an idea and mentally jump straight to the Sam Altman outcome. But the funding market is not built to reward most ideas, and it is not even built to reward most prototypes. It is built to filter aggressively, concentrate capital, and back a very small number of ventures that fit the logic of each funder or programme.
Key Takeaways
- Funding is structurally selective and most applicants do not succeed.
- A good idea on its own is rarely enough to win serious funding.
- Fit with the funder’s logic matters more than founder enthusiasm.
- Capital is increasingly concentrated by geography, theme and scale.
The First Hard Truth
Many founders start with a simple assumption: idea, prototype, pitch deck, funding. It sounds logical, but that is not how most funding decisions are made.
The market is not designed to reward optimism. It is designed to screen, compare, filter and reject. What gets funded is usually not the most passionate story, but the project that best matches the exact decision logic of a funder, investor or programme.
That is why the real question is not whether an idea sounds good. The real question is whether it fits one of the things funders actually back: proven research excellence, a credible commercial route, strategic relevance to a programme, or the possibility of very large returns.
Europe Is Highly Selective
In Europe, the numbers are already severe before a founder even reaches the elite instruments. Preliminary 2025 figures reported for Horizon Europe placed the overall success rate at around 12%, with some calls falling as low as 2%.
That means in many cases between 88% and 98% of applicants do not receive funding. These are not marginal rejection rates. They show a system built around scarcity and competition.
For research-led founders and academic applicants, the picture is only slightly less harsh. ERC Starting Grants 2024 recorded 3,474 submitted proposals and 494 selected, which corresponds to a success rate of about 14.2%. It is prestigious funding, but it still rejects the large majority of applicants.
The EIC Accelerator: A Rejection Machine by Design
The EIC Accelerator is often seen as one of the most attractive public innovation instruments in Europe. It is also one of the hardest to win.
In the February 2025 announcement, the European Innovation Council stated that 71 companies were selected out of 1,211 submitted proposals. That is a success rate of about 5.9%.
Put differently, roughly 94 out of every 100 applicants did not get through. Even reaching the interview stage offered little comfort. Out of 431 companies invited to jury interviews, only 71 were selected in the end. That means only around 16.5% of interview-stage applicants won funding.
This is important because many founders still speak about these programmes as if the main challenge were writing a stronger application. In reality the challenge is much deeper. A proposal must be exceptional for that exact instrument, in that exact cycle, against that exact field of competitors.
Outside Europe, the Picture Is Not Kinder
The pattern does not improve much once we look beyond Europe. NIH data for SBIR grants show that in 2024 the Phase I success rate was 10% and the Phase II success rate was 18%. In 2025 those figures fell to 8% and 15%.
That means rejection remains the norm even in one of the world’s best-known public innovation funding systems. The brand may be different, the language may be different, but the underlying reality is similar: many apply, few are funded.
Private Capital Is Often Even Harder
Many founders imagine venture capital as the more open alternative. In reality it is often harsher than public funding.
Crunchbase noted that only 0.05% of startups ultimately receive venture capital. Even allowing for differences in methodology, the wider message remains the same. Venture funding is not a broad financing path for ordinary businesses. It is an outlier path for a very small minority.
This matters because startup culture often presents VC as a natural next step. It is not. It is a narrow route shaped by extreme selectivity, strong pattern recognition, geographic preference and narrative concentration.
Capital Is Concentrated, Not Evenly Available
A second uncomfortable fact is that funding is not only selective. It is also geographically uneven.
Europe does create strong companies and performs relatively well at seed stage, but it still receives a smaller share of global venture capital than its economic weight would suggest. One 2025 industry analysis placed Europe at 17% of global VC funding in 2024, while accounting for around 25% of global GDP. North America, by contrast, captured 56% of global VC funding with roughly 30% of global GDP.
This means that even very capable European founders are operating in a market where less capital is available relative to the size of the economy.
The concentration sharpens further when capital clusters around a few sectors. OECD reported in 2026 that equity financing was recovering in many countries, but in an uneven way, concentrated in a small number of large AI rounds. CB Insights also reported that US startups raised $328 bn in 2025, representing 70% of global venture funding, while AI companies captured 48% of total global venture funding that year.
So when people say that money is available, the missing part of the sentence is this: it is available for a narrow set of geographies, sectors, narratives and timing conditions.
What Actually Improves the Odds
Most founders do not fail because the original idea was foolish. They fail because funding is structurally selective and because the project does not meet the exact criteria that drive a positive decision.
A prototype helps, but on its own it rarely changes everything. In many cases a weak consortium, a weak route to market, poor timing, unclear impact logic, or stronger competing applicants will end the process long before enthusiasm matters.
The probability of success starts to improve when the project shows one or more of the following: strong scientific novelty, early market traction, a credible team, a well-matched consortium, strategic relevance to the programme, and a proposal written for the funder rather than for the founder’s ego.
A More Realistic Funding Logic
- Ideas are not enough — funders usually need evidence, traction, or exceptional scientific value.
- Fit matters more than passion — the proposal must align with the exact logic of the instrument.
- Competition is brutal — many strong applications still fail because the field is crowded.
- Capital is concentrated — geography, theme, scale and timing all influence outcomes.
- Most applicants are rejected — rejection is not an exception in funding markets, it is the standard result.
A Fair Conclusion
If someone has only an idea, the chance of serious funding is usually very low. If they have a prototype, the picture improves, but not dramatically on its own.
The real improvement comes when a founder can show evidence that matches what the funder is actually trying to buy into: novelty, traction, fit, strategic relevance, or scale potential.
That is less romantic than startup mythology, but it is far closer to the truth. Funding does not reward hope. It rewards fit, proof, timing and a level of competitiveness that most people underestimate.
CB Insights (2026) State of Venture 2025.
Crunchbase (2025) ‘So You’re Thinking About Seeking Venture Capital? Here’s What You Should Expect’. Crunchbase.
European Innovation Council (2025) ‘EIC Accelerator – 71 companies selected in the most competitive funding round so far’. European Commission / EIC.
European Research Council (2024a) ‘ERC Starting Grants 2024: Statistics’. European Research Council.
European Research Council (2024b) ‘ERC grants €780m to emerging science talent in Europe’. European Research Council.
NIH Data Book (2026) ‘SBIR Grants: Success Rates of Competing Applications, by Phase’. National Institutes of Health.
OECD (2026) Financing SMEs and Entrepreneurs 2026. OECD Publishing.
OpenAI (2026) ‘Scaling AI for everyone’. OpenAI.
Science|Business (2025) ‘Data corner: Horizon success rates are dropping’. Science|Business.
State of European Angels (2025) State of European Angels. Nordic Angels / BCG analysis.